Company: AIP
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048977
Chunk: 253

Company: Arteris, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 8
Chunk 253
---
20)$(0.63)$(0.66)Since the Company was in a loss position for all periods presented, the diluted earnings per share was equal to the basic earnings per share as the effect of potentially dilutive securities would have been antidilutive.The following table summarizes the potentially dilutive securities that were excluded from the calculation of diluted earnings per share because they would be anti-dilutive:As ofSeptember 30, 2025September 30, 2024Stock options1,818,539 2,259,303 Restricted stock units4,760,502 5,647,231 Restricted common shares issued for business combination234,859 234,859 Shares committed under the 2021 ESPP73,780 81,545 Total6,887,680 8,222,938 

12

5.    INVESTMENTS

The following tables summarize the fair value and amortized cost of the Company’s cash equivalents and available-for-sale securities by major security type (in thousands):As of September 30, 2025Amortized CostUnrealized GainsAggregate Fair ValueAssets: Corporate bonds$25,293 $60 $25,353 U.S. government agency securities8,445 1 8,446 U.S. treasury securities5,000 4 5,004 Money market funds3,389 — 3,389 Commercial paper999 — 999 Total financial assets$43,126 $65 $43,191 As of December 31, 2024Amortized CostUnrealized GainsAggregate Fair ValueAssets: U.S. government agency securities$18,730 $16 $18,746 U.S. treasury securities11,752 1 11,753 Money market funds10,410 — 10,410 Corporate bonds8,157 5 8,162 Total financial assets$49,049 $22 $49,071 The maturity dates of the Company’s investments are as follows (in thousands):September 30, 2025Less than one year$25,954 1-2 years17,237 Total$43,191 

As of September 30, 2025, securities with a fair-value of $2.1 million were in a continuous net unrealized loss position for more than 12 months, and the related losses were immaterial. As of December 31